Repare Therapeutics Inc. (RPTX)

Repare Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	80.54	111.27	159.52	334.43	326.18	94.8
Short-Term Investments	98.89	112.36	184.42	7.44	7.53	-
Cash & Short-Term Investments	179.43	223.63	343.94	341.87	333.71	94.8
Cash Growth	-28.25%	-34.98%	0.61%	2.44%	252.03%	783.39%
Accounts Receivable	-	2.05	1.53	-	-	-
Other Receivables	14.23	13.26	2.8	3.23	6.16	3.06
Receivables	14.23	15.31	4.32	3.23	6.16	3.06
Prepaid Expenses	6.74	4.75	5.72	6.31	6.68	0.72
Total Current Assets	200.4	243.69	353.98	351.41	346.55	98.57
Property, Plant & Equipment	5.22	7.54	9.6	13.1	8.62	3.42
Long-Term Deferred Tax Assets	-	-	-	3.62	1.41	0.13
Other Long-Term Assets	0.77	2.67	0.5	0.59	0.5	0.57
Total Assets	206.39	253.9	364.08	368.72	357.09	102.7
Accounts Payable	10.66	2.4	0.46	2.3	2.25	2.13
Accrued Expenses	17.68	23.86	21.37	16.53	5.79	1.27
Current Portion of Leases	2.22	2.4	2.17	1.72	0.7	0.63
Current Income Taxes Payable	-	-	1.24	0.52	0.02	0.22
Current Unearned Revenue	-	10.22	53.1	11.92	2.07	-
Other Current Liabilities	0.53	0.19	0.27	2.1	0.18	0
Total Current Liabilities	31.08	39.08	78.62	35.09	11.01	4.25
Long-Term Leases	0.35	1.01	3.26	5.59	3.31	0.44
Long-Term Unearned Revenue	-	1.73	2.68	39.61	55.93	8.14
Total Liabilities	31.43	41.82	84.56	80.29	70.26	12.83
Common Stock	486.67	483.35	482.03	480.7	384.31	0
Additional Paid-In Capital	77.27	61.81	37.23	17.99	5.88	3.81
Retained Earnings	-389.13	-333.11	-239.31	-210.27	-103.36	-49.94
Comprehensive Income & Other	0.14	0.03	-0.43	-	-	-
Total Common Equity	174.96	212.08	279.52	288.42	286.83	-46.13
Shareholders' Equity	174.96	212.08	279.52	288.42	286.83	89.87
Total Liabilities & Equity	206.39	253.9	364.08	368.72	357.09	102.7
Total Debt	2.56	3.41	5.43	7.31	4.01	1.06
Net Cash (Debt)	176.87	220.22	338.51	334.55	329.71	93.73
Net Cash Growth	-28.15%	-34.95%	1.18%	1.47%	251.75%	1037.40%
Net Cash Per Share	4.18	5.23	8.07	8.85	16.45	61.33
Filing Date Shares Outstanding	42.51	42.18	42.08	41.87	36.9	1.71
Total Common Shares Outstanding	42.51	42.18	42.04	41.85	36.9	1.53
Working Capital	169.32	204.61	275.36	316.33	335.54	94.33
Book Value Per Share	4.12	5.03	6.65	6.89	7.77	-30.18
Tangible Book Value	174.96	212.08	279.52	288.42	286.83	-46.13
Tangible Book Value Per Share	4.12	5.03	6.65	6.89	7.77	-30.18
Machinery	-	8.97	7.06	6.51	5.24	3
Leasehold Improvements	-	2.55	2.52	2.47	0.71	0.49

Source: S&P Capital IQ. Standard template. Financial Sources.